Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.37

+0.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (7995)	3/11/2003 12:49:24 AM
From: mopgcw	Read Replies (1) of 52153

OT: I would submit that Poole is far from right on and unfortunately adds no value to the tired diatribe on FRE/FNM, and the implicit guarantee. Every company the size of the GSE's is a disaster waiting to happen. Citibank, JPM, anyone??? & the old argument that they hold less capital than banks --last time I checked, Freddie was not taking losses on their Enron/Worldcom position or Argentina like the banks were, thus the comparison is difficult at best. Yes, refinances are way up given low rates, but are cash-out refis increasing (I honestly do not know the answer here)? The argument on whether there is or is not residential bubble is interesting on both sides (yes credit costs have increased). But importantly Poole does not discuss the steps FRE/FNMA have taken to manage the credit risks in their portfolios such as reinsurance etc..

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next